Embedded Files
A Four-Layer Computational Framework for Migraine Stratification, Safety Signal Detection, and Longitudinal Outcome Modeling in Adolescent Females
December 2025- Current
Introduction
Introduction
Some headaches aren't so ordinary. In some cases, they are an incessant pounding behind the eyes, an unsettling nausea, and a light sensitivity so sharp that even a crack under the door seems bright. They can last hours, sometimes days.
A friend of mine has experienced this reality for years. It is a wretched experience to witness someone you care about endure something you cannot immediately fix. I'll never claim to know their experience: no one who hasn't lived it can. But even still, I've seen how much it takes.
This is a profoundly understudied story. Adolescents with severe migraine fall through the gaps of a research enterprise built largely for adults. Clinical trials and databases center on older populations and treatment response becomes a snapshot rather than the rolling film it really is. No existing framework connects genetic factors and clinical phenotype to immediate and long-term medication effects.
I built the Migraine Stratification Outcomes Framework (MiSOF) to address these gaps (which has since grown into a central part of my work). It is a unified computational structure for stratifying migraine patients, anticipating treatment responses, and tracing outcomes across time. Further, MiSOF prioritizes a demographic overlooked by existing tools: adolescent females, whose migraines remain still poorly characterized and poorly treated.
Cheers,
A.X.
MiSOF: Series Explanation
MiSOF: Series Explanation
The Migraine Stratification Outcomes Framework (MiSOF) operates as a 4-layer pipeline. Each project performs a distinct analytical function and, together, they turn raw data into clinically relevant insights.
The 4 layers follow an order: ChanVar feeds into TraitStrata, TraitStrata into SigVigil, and then NeuroTrack. Each layer builds on the previous.
ChanVar (Layer 1)
ChanVar handles variable encoding and feature harmonization. It takes heterogeneous clinical data and structures it into analyzable channels. The name reflects a dual focus: clinical variables and the genetic channelopathies behind some rare forms of severe migraine. ChanVar is the foundation since without clean variable representation, downstream stratification cannot succeed.
TraitStrata (Layer 2)
TraitStrata performs phenotypic subgroup identification. It applies clustering methods to clinical and behavioral traits. The goal is to separate patients who look similar on the surface but differ in treatment response, side effect burden, or long term trajectory. This layer addresses a real clinical puzzle: two patients with the same diagnosis can experience very different outcomes. TraitStrata aims to capture that kind of heterogeneity.
SigVigil (Layer 3)
SigVigil detects adverse effect signals in pharmacovigilance data. It analyzes datasets modeled after FAERS. The focus is not only on whether a side effect occurs but on temporal patterns. When does a side effect first appear after someone starts a medication? Does it fade, plateau, or keep building? Adolescent patients are poorly represented in existing safety databases, so SigVigil prioritizes this exact population.
NeuroTrack (Layer 4)
NeuroTrack models longitudinal treatment response. It integrates stratified phenotypes from TraitStrata with safety signals from SigVigil. The output is a trajectory model: some patients improve and wean off medication while others cycle through multiple drugs with incomplete benefit and accumulating side effects. NeuroTrack asks what distinguishes these paths, and provides an answer that can inform earlier clinical decisions.
MiSOF: Layman's Guide
MiSOF: Layman's Guide
You can think of MiSOF as a sorting and prediction system for severe migraine.
The first step organizes patient data into a clean format. The second step finds natural subgroups among patients: i.e. some people might have mostly pain with nausea while others extreme light sensitivity or rare attacks. These subgroups matter because they may respond to different treatments.
The third step looks at medication side effects and asks not just which side effects happen, but when they happen during treatment. This is especially important for teenagers since, biologically, they might react differently than adults. The fourth step puts everything together by modeling how a patient's migraine may change over months or years. Does the person get better on a certain drug? Do side effects force a switch? What does the whole journey look like?
Of course, MiSOF does not treat patients directly. It analyzes public data to find patterns that current research misses with the goal of better stratification today and better treatment guidance tomorrow.
Closing Remarks
Closing Remarks
MiSOF will not produce a cure tomorrow and might not produce one ever. But it does ask questions that should've been asked decades ago, represents treatment response as a trajectory, and finds safety signals for people that established systems ignore.
I dedicate these things to my friend, who unintentionally set me on a path to everything I've since become. They may never read this, but if they do: I hope you know that even if you don’t want to ask for much, everything is still yours. What you carry will never decide what you can become, and the world will always be yours for the taking.
Until the answers arrive,
A.X.
Page updated
Google Sites
Report abuse